Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
Date
2018-02-24Author
Powles, T
Duran, I
van der Heijden, MS
Loriot, Y
Vogelzang, NJ
De Giorgi, U
Oudard, S
Retz, MM
Castellano, D
Bamias, A
Flechon, A
Gravis, G
Hussain, SA
Takano, T
Leng, N
Kadel III, EE
Banchereau, R
Hegde, PS
Mariathasan, S
Cui, N
Shen, X
Derieth, CL
Green, MC
Ravaud, A
Metadata
Show full item recordCollections
Publisher
Elsevier
Journal
The Lancet
Recommended, similar items
The following license files are associated with this item: